| Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies? P Magalhães, M Pejchinovski, K Markoska, M Banasik, M Klinger, ... Scientific Reports 7 (1), 16915, 2017 | 78 | 2017 |
| Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies P Magalhães, HA Lashuel npj Parkinson's Disease 8 (1), 93, 2022 | 52 | 2022 |
| Comparison of urine and plasma peptidome indicates selectivity in renal peptide handling P Magalhaes, C Pontillo, M Pejchinovski, J Siwy, M Krochmal, ... PROTEOMICS–Clinical Applications 12 (5), 1700163, 2018 | 50 | 2018 |
| Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy M Krochmal, G Kontostathi, P Magalhães, M Makridakis, J Klein, H Husi, ... Scientific reports 7 (1), 15160, 2017 | 36 | 2017 |
| A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity ST Kumar, AL Mahul-Mellier, RN Hegde, G Rivière, R Moons, ... Science advances 8 (17), eabn0044, 2022 | 30 | 2022 |
| Urinary glycopeptide analysis for the investigation of novel biomarkers I Belczacka, M Pejchinovski, M Krochmal, P Magalhães, M Frantzi, ... PROTEOMICS–Clinical Applications 13 (3), 1800111, 2019 | 27 | 2019 |
| The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease F Verbeke, J Siwy, W Van Biesen, H Mischak, A Pletinck, E Schepers, ... Nephrology Dialysis Transplantation 36 (5), 811-818, 2021 | 26 | 2021 |
| Urinary proteome signature of Renal Cysts and Diabetes syndrome in children P Ricci, P Magalhães, M Krochmal, M Pejchinovski, E Daina, MR Caruso, ... Scientific Reports 9 (1), 2225, 2019 | 24 | 2019 |
| Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases P Magalhães, H Mischak, P Zürbig Current opinion in nephrology and hypertension 25 (6), 494-501, 2016 | 22 | 2016 |
| Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity HA Lashuel, AL Mahul-Mellier, S Novello, RN Hegde, Y Jasiqi, MF Altay, ... npj Parkinson's Disease 8 (1), 136, 2022 | 17* | 2022 |
| Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes P Magalhaes, P Zürbig, H Mischak, E Schleicher Clinical Kidney Journal 14 (1), 269-276, 2021 | 17 | 2021 |
| Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model LL Niborski, M Paces-Fessy, P Ricci, A Bourgeois, P Magalhães, ... Disease Models & Mechanisms 14 (5), dmm047498, 2021 | 15 | 2021 |
| Urinary peptidome analyses for the diagnosis of chronic kidney disease in dogs L Pelander, V Brunchault, B Buffin-Meyer, J Klein, B Breuil, P Zürbig, ... The Veterinary Journal 249, 73-79, 2019 | 15 | 2019 |
| Amniotic fluid peptides predict postnatal kidney survival in developmental kidney disease J Klein, B Buffin-Meyer, F Boizard, N Moussaoui, O Lescat, B Breuil, ... Kidney International 99 (3), 737-749, 2021 | 14 | 2021 |
| Artificial intelligence–coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases D Kavungal, P Magalhães, ST Kumar, R Kolla, HA Lashuel, H Altug Science Advances 9 (28), eadg9644, 2023 | 12 | 2023 |
| Comparison of the amniotic fluid and fetal urine peptidome for biomarker discovery in renal developmental disease C Fédou, B Breuil, I Golovko, S Decramer, P Magalhães, F Muller, ... Scientific Reports 10 (1), 21706, 2020 | 11 | 2020 |
| Urinary biomarkers for renal tract malformations P Magalhães, JP Schanstra, E Carrick, H Mischak, P Zürbig Expert review of proteomics 13 (12), 1121-1129, 2016 | 10 | 2016 |
| Bases sociais do voto nas legislativas de 2022 J Cancela, P Magalhães Pedro Magalhães. political scientist, 2022 | 8 | 2022 |
| Urinary peptidome and diabetic retinopathy in the DIRECT‐Protect 1 and 2 trials V Rotbain Curovic, P Magalhães, T He, TW Hansen, H Mischak, ... Diabetic Medicine 38 (9), e14634, 2021 | 7 | 2021 |
| Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies. NPJ Parkinson’s Dis 2022; 8: 93 P Magalhães, HA Lashuel PMID:[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 7 | |
Harald MischakMosaiques DiagnosticsBestätigte E-Mail-Adresse bei mosaiques.de
